{"id":35892,"date":"2025-12-12T04:39:36","date_gmt":"2025-12-12T10:39:36","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=35892"},"modified":"2026-01-09T11:00:29","modified_gmt":"2026-01-09T17:00:29","slug":"brakke-consulting-viewpoint-december-12-2025","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/brakke-consulting-viewpoint-december-12-2025\/","title":{"rendered":"\u5e03\u62c9\u514b\u89c2\u70b9 2025 \u5e74 12 \u6708 12 \u65e5"},"content":{"rendered":"<p><span style=\"font-family: Arial,Helvetica;\" data-olk-copy-source=\"MessageBody\">\u5728\u660e\u5e74\u7684VMX\u548cWVC\u884c\u4e1a\u6982\u89c8\u4f1a\u8bae\u4e0a\uff0c\u6211\u4eec\u5c06\u91cd\u70b9\u5173\u6ce8\u52a8\u7269\u5065\u5eb7\u9886\u57df\u7684\u521b\u65b0\u3002\u8fd1\u671f\u4eba\u7c7b\u5065\u5eb7\u9886\u57df\u7684\u53d1\u5c55\u51f8\u663e\u4e86\u901a\u8fc7\u7b80\u5316\u76d1\u7ba1\u6d41\u7a0b\u800c\u975e\u4ec5\u4ec5\u4f9d\u8d56\u4f01\u4e1a\u81ea\u8eab\u7814\u53d1\u6210\u679c\u6765\u52a0\u901f\u521b\u65b0\u7684\u52aa\u529b\u3002.<br \/>\n<\/span><\/p>\n<p><span style=\"font-family: Arial,Helvetica;\">\u4e24\u9879\u503c\u5f97\u5173\u6ce8\u7684\u63d0\u8bae\u6d6e\u51fa\u6c34\u9762\uff1a\u4e00\u662f\u57fa\u4e8e\u4e00\u9879\u7cbe\u5fc3\u8bbe\u8ba1\u7684\u4e34\u5e8a\u8bd5\u9a8c\u800c\u975e\u4e24\u9879\u4e34\u5e8a\u8bd5\u9a8c\u6279\u51c6\u4eba\u4f53\u4ea7\u54c1\uff1b\u4e8c\u662f\u964d\u4f4e\u65e9\u671f\u516c\u53f8\u5728\u7f8e\u56fd\u5f00\u5c55\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7528\u6237\u8d39\u7528\u3002\u00a0<u><a title=\"https:\/\/www.fiercebiotech.com\/biotech\/markets-thinking-backwards-fdas-1-trial-approval-plan-would-boost-rd-spend-jefferies\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/markets-thinking-backwards-fdas-1-trial-approval-plan-would-boost-rd-spend-jefferies\" data-linkindex=\"74\" data-auth=\"NotApplicable\">\u7b2c\u4e00\u4e2a\u63d0\u6848<\/a><\/u>\u00a0\u867d\u7136\u5f15\u53d1\u4e86\u4e00\u4e9b\u62c5\u5fe7\uff0c\u4f46\u8bb8\u591a\u4eba\u8ba4\u4e3a\uff0c\u52a0\u5feb\u5ba1\u6279\u901f\u5ea6\u3001\u964d\u4f4e\u5ba1\u6279\u6210\u672c\u53ef\u4ee5\u4fc3\u8fdb\u521b\u65b0\u3002\u00a0<u><a title=\"https:\/\/www.fiercebiotech.com\/biotech\/fda-floats-user-fee-cuts-early-stage-us-trials-additional-fees-overseas-development\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/fda-floats-user-fee-cuts-early-stage-us-trials-additional-fees-overseas-development\" data-linkindex=\"75\" data-auth=\"NotApplicable\">\u7b2c\u4e8c\u9879\u63d0\u6848<\/a><\/u> \u4e0e\u6b63\u5728\u8fdb\u884c\u7684 PDUFA \u8c08\u5224\u6709\u5173\uff0c\u5177\u4f53\u64cd\u4f5c\u7ec6\u8282\u4ecd\u5728\u8ba8\u8bba\u4e2d\u3002.\u00a0<\/span><\/p>\n<p><span style=\"font-family: Arial,Helvetica;\">\u4ee4\u4eba\u9f13\u821e\u7684\u662f\uff0c\u8fd9\u4e9b\u4e3e\u63aa\u90fd\u6e90\u81ea\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u3002\u4eba\u7c7b\u5065\u5eb7\u884c\u4e1a\u56e2\u4f53\u4e5f\u5728\u79ef\u6781\u8d21\u732e\u60f3\u6cd5\uff0c\u6211\u4eec\u81ea\u5df1\u7684\u52a8\u7269\u5065\u5eb7\u534f\u4f1a\uff08AHI\uff09\u6700\u8fd1\u4e5f\u5efa\u8bae\u5bf9\u836f\u54c1\u548c\u517d\u533b\u7ba1\u7406\u4e2d\u5fc3\uff08CVM\uff09\u8fdb\u884c\u76d1\u7ba1\u6539\u9769\u5e76\u63d0\u9ad8\u6d41\u7a0b\u6548\u7387\u3002\u968f\u7740\u300a\u7f8e\u56fd\u5ba0\u7269\u7528\u836f\u54c1\u6cd5\u6848\u300b\uff08ADUFA\uff09\u8c08\u5224\u5c06\u4e8e\u660e\u5e74\u542f\u52a8\uff0c\u52a8\u7269\u5065\u5eb7\u9886\u57df\u7684\u76d1\u7ba1\u521b\u65b0\u6216\u8bb8\u6307\u65e5\u53ef\u5f85\u3002\u00a0<\/span><\/p>\n<p><span style=\"font-family: Arial,Helvetica;\"><i>\u7f57\u4f2f\u7279\u00b7\u743c\u65af<\/i><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>\u5728\u660e\u5e74\u7684VMX\u548cWVC\u884c\u4e1a\u6982\u89c8\u4f1a\u8bae\u4e0a\uff0c\u6211\u4eec\u5c06\u91cd\u70b9\u5173\u6ce8\u52a8\u7269\u5065\u5eb7\u9886\u57df\u7684\u521b\u65b0\u3002\u4eba\u7c7b\u5065\u5eb7\u9886\u57df\u7684\u6700\u65b0\u8fdb\u5c55\u51f8\u663e\u4e86\u901a\u8fc7\u7b80\u5316\u76d1\u7ba1\u6d41\u7a0b\u800c\u975e\u4ec5\u4ec5\u4f9d\u8d56\u4f01\u4e1a\u81ea\u8eab\u7814\u53d1\u6765\u52a0\u901f\u521b\u65b0\u7684\u52aa\u529b\u3002\u76ee\u524d\u5df2\u63d0\u51fa\u4e24\u9879\u503c\u5f97\u5173\u6ce8\u7684\u63d0\u6848\uff1a\u4e00\u662f\u57fa\u4e8e\u4e00\u9879\u7cbe\u5fc3\u8bbe\u8ba1\u7684\u4e34\u5e8a\u8bd5\u9a8c\u800c\u975e\u4e24\u9879\u6765\u6279\u51c6\u4eba\u7c7b\u4ea7\u54c1\uff1b\u4e8c\u662f\u964d\u4f4e\u65e9\u671f\u516c\u53f8\u5728\u7f8e\u56fd\u5f00\u5c55\u4e34\u5e8a\u8bd5\u9a8c\u7684\u7528\u6237\u8d39\u7528\u3002\u867d\u7136\u7b2c\u4e00\u9879\u63d0\u6848\u5f15\u53d1\u4e86\u4e00\u4e9b\u62c5\u5fe7\uff0c\u4f46\u8bb8\u591a\u4eba\u8ba4\u4e3a\u5b83\u53ef\u4ee5\u901a\u8fc7\u52a0\u5feb\u5ba1\u6279\u901f\u5ea6\u548c\u964d\u4f4e\u6210\u672c\u6765\u4fc3\u8fdb\u521b\u65b0\u3002\u7b2c\u4e8c\u9879\u63d0\u6848\u4e0e\u6b63\u5728\u8fdb\u884c\u7684\u300a\u5904\u65b9\u836f\u7528\u6237\u4ed8\u8d39\u6cd5\u6848\u300b\uff08PDUFA\uff09\u8c08\u5224\u6709\u5173\uff0c\u5176\u5177\u4f53\u64cd\u4f5c\u7ec6\u8282\u4ecd\u5728\u8ba8\u8bba\u4e2d\u3002\u4ee4\u4eba\u9f13\u821e\u7684\u662f\uff0c\u8fd9\u4e9b\u4e3e\u63aa\u5747\u6e90\u81ea\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u3002\u4eba\u7c7b\u5065\u5eb7\u884c\u4e1a\u56e2\u4f53\u4e5f\u5728\u79ef\u6781\u8d21\u732e\u60f3\u6cd5\uff0c\u6211\u4eec\u81ea\u5df1\u7684\u52a8\u7269\u5065\u5eb7\u534f\u4f1a\uff08AHI\uff09\u6700\u8fd1\u4e5f\u5411\u7f8e\u56fd\u517d\u533b\u548c\u517d\u533b\u5b66\u9662\uff08CVM\uff09\u63d0\u51fa\u4e86\u76d1\u7ba1\u6539\u9769\u548c\u6d41\u7a0b\u6548\u7387\u63d0\u5347\u7684\u5efa\u8bae\u3002\u968f\u7740\u300a\u52a8\u7269\u7528\u6237\u4ed8\u8d39\u6cd5\u6848\u300b\uff08ADUFA\uff09\u8c08\u5224\u5c06\u4e8e\u660e\u5e74\u542f\u52a8\uff0c\u52a8\u7269\u5065\u5eb7\u9886\u57df\u7684\u76d1\u7ba1\u521b\u65b0\u6216\u8bb8\u4e5f\u5c06\u7d27\u968f\u7f57\u4f2f\u7279\u00b7\u743c\u65af\u4e4b\u540e\u3002<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-35892","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-consulting-viewpoint-december-12-2025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"At next year\u2019s Industry Overviews at VMX and WVC, we will focus on innovation in animal health. Recent developments in human health highlight efforts to accelerate innovation by streamlining regulatory processes rather than relying solely on company-driven advances. Two notable proposals have emerged: approving human products based on a single well-designed trial instead of two and\u00a0reducing user fees for early-stage companies conducting U.S. clinical trials. While the\u00a0first proposal\u00a0has raised concerns, many believe it could foster innovation by making approvals faster and less costly. The\u00a0second proposal relates to ongoing PDUFA negotiations, with operational details still under discussion.\u00a0 Encouragingly, these initiatives originate within the FDA. Human health industry groups are also contributing ideas, and our own animal health association (AHI) recently recommended regulatory reforms and process efficiencies for CVM. With ADUFA negotiations beginning next year, regulatory innovation in animal health may not be far behind\u00a0 Robert Jones\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/brakke-consulting-viewpoint-december-12-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-12T10:39:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-09T17:00:29+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint December 12, 2025\",\"datePublished\":\"2025-12-12T10:39:36+00:00\",\"dateModified\":\"2026-01-09T17:00:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/\"},\"wordCount\":154,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/\",\"url\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2025-12-12T10:39:36+00:00\",\"dateModified\":\"2026-01-09T17:00:29+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint December 12, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/brakke-consulting-viewpoint-december-12-2025\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"At next year\u2019s Industry Overviews at VMX and WVC, we will focus on innovation in animal health. Recent developments in human health highlight efforts to accelerate innovation by streamlining regulatory processes rather than relying solely on company-driven advances. Two notable proposals have emerged: approving human products based on a single well-designed trial instead of two and\u00a0reducing user fees for early-stage companies conducting U.S. clinical trials. While the\u00a0first proposal\u00a0has raised concerns, many believe it could foster innovation by making approvals faster and less costly. The\u00a0second proposal relates to ongoing PDUFA negotiations, with operational details still under discussion.\u00a0 Encouragingly, these initiatives originate within the FDA. Human health industry groups are also contributing ideas, and our own animal health association (AHI) recently recommended regulatory reforms and process efficiencies for CVM. With ADUFA negotiations beginning next year, regulatory innovation in animal health may not be far behind\u00a0 Robert Jones","og_url":"https:\/\/brakkeconsulting.com\/zh\/brakke-consulting-viewpoint-december-12-2025\/","og_site_name":"Brakke Consulting Website","article_published_time":"2025-12-12T10:39:36+00:00","article_modified_time":"2026-01-09T17:00:29+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Amanda McDavid","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint December 12, 2025","datePublished":"2025-12-12T10:39:36+00:00","dateModified":"2026-01-09T17:00:29+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/"},"wordCount":154,"articleSection":["Viewpoints"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/","url":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2025-12-12T10:39:36+00:00","dateModified":"2026-01-09T17:00:29+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/brakke-consulting-viewpoint-december-12-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint December 12, 2025"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"\u963f\u66fc\u8fbe\u00b7\u9ea6\u514b\u6234\u7ef4","url":"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/35892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=35892"}],"version-history":[{"count":4,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/35892\/revisions"}],"predecessor-version":[{"id":36023,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/35892\/revisions\/36023"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=35892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=35892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=35892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}